Fred Hutch News
Recently, a team of biostatisticians led by Fred Hutch Cancer Center’s Peter Gilbert, PhD, garnered $17 million in funding from BARDA to identify correlates of protection (molecular shorthands that stand in for vaccine efficacy) for COVID-19 vaccines being tested through Project NextGen. Gilbert is a professor of biostatistics at the University of Washington School of Publich Health
Category